P James Scrivens

Title: P James Scrivens: Innovator in Tyrosine Hydroxylase Variants

Introduction

P James Scrivens is a notable inventor based in St. Constant, CA. He has made significant contributions to the field of biochemistry, particularly in the development of tyrosine hydroxylase variants. His work focuses on enhancing the production of L-DOPA, a critical compound in the treatment of various neurological disorders.

Latest Patents

P James Scrivens holds a patent for "Tyrosine hydroxylase variants and methods of use thereof." This patent describes a variant tyrosine hydroxylase that increases the production of L-DOPA in host cells expressing the enzyme. The disclosure includes nucleic acids encoding the variant tyrosine hydroxylase and genetically modified host cells. Additionally, it outlines methods for producing L-DOPA, benzylisoquinoline alkaloids (BIA), and detecting L-DOPA levels in cells. The patent also provides methods for identifying tyrosine hydroxylase variants that enhance L-DOPA production and gene products that increase tyrosine production.

Career Highlights

Throughout his career, P James Scrivens has worked with esteemed institutions, including the University of California and Valorbec S.e.c. His innovative research has contributed to advancements in biochemistry and therapeutic applications.

Collaborations

P James Scrivens has collaborated with notable colleagues, including Vincent J J Martin and Lauren Narcross. Their combined expertise has furthered research in the field and led to significant discoveries.

Conclusion

P James Scrivens is a distinguished inventor whose work on tyrosine hydroxylase variants has the potential to impact the treatment of neurological disorders. His contributions to biochemistry and collaboration with esteemed colleagues highlight his commitment to innovation in the field.